Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | AMGN | VRTX | BMY | REGN |
| Company | Cybin Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.0500 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 3.2000 | 322.60 | 405.67 | 44.33 | 947.08 |
| Low | 2.8736 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 3.0200 | 314.65 | 400.52 | 43.88 | 944.78 |
| Change | -0.0400 | +36.26 | +0.36 | +0.18 | +7.17 |
| % Change | -1.31% | +13.02% | +0.09% | +0.41% | +0.76% |
| Volume | 864,300 | 5,216,147 | 284,870 | 3,827,485 | 122,689 |
| 20-Day Average Volume | 1,094,590 | 2,414,331 | 981,596 | 14,040,353 | 496,554 |
| Previous Close | 3.0600 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 272.39 | 398.32 | 47.46 | 909.07 |
| 20-Day Raw Stochastic | 71.64% | 85.63% | 48.93% | 7.03% | 88.93% |
| 20-Day Relative Strength | 62.45% | 72.89% | 45.36% | 28.82% | 55.11% |
| Weighted Alpha | +130.72 | +35.13 | +13.46 | -36.81 | +23.84 |
| Today's Opinion | N/A | 24% Buy | 8% Buy | 100% Sell | 48% Buy |
| Previous Opinion | N/A | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | N/A | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +16.19% since 04/26/24 | +0.33% since 04/26/24 | -2.07% since 04/26/24 | +6.55% since 04/26/24 |
| Low | 2.7300 on 07/29/21 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 3.3800 on 08/02/21 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 946.81 on 05/03/24 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +14.31% since 04/03/24 | -2.45% since 04/03/24 | -15.83% since 04/03/24 | -1.05% since 04/03/24 |
| Low | 2.1105 on 07/08/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 3.3800 on 08/02/21 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | -2.94% since 02/02/24 | -6.09% since 02/02/24 | -9.83% since 02/02/24 | -0.44% since 02/02/24 |
| Low | 1.3429 on 06/01/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 3.3800 on 08/02/21 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | +16.25% since 11/03/23 | +6.01% since 11/03/23 | -16.85% since 11/03/23 | +15.19% since 11/03/23 |
| Low | 0.9500 on 03/30/21 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 3.3800 on 08/02/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 148,598 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 650,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -24,420,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | N/A | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |